Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Therapeutic Drug Monitoring: Affecting Factors01:29

Therapeutic Drug Monitoring: Affecting Factors

400
Therapeutic Drug Monitoring (TDM) is the clinical practice of measuring specific drug levels in a patient's blood or body tissues to manage and optimize therapy. TDM is crucial for drugs with narrow therapeutic windows, like warfarin and phenytoin, where incorrect doses can lead to treatment failure or severe side effects. This monitoring ensures the dosage administered is within a safe and effective range. The factors affecting therapeutic drug monitoring include:Patient-Specific Factors:a.
400
Therapeutic Drug Monitoring: Overview and Classification01:16

Therapeutic Drug Monitoring: Overview and Classification

582
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood at designated intervals to ensure the drug concentration stays within a therapeutic range. This monitoring is crucial for optimizing individual dosage regimens, enhancing therapeutic efficacy, and minimizing drug-related toxicity. TDM is vital for drugs with narrow therapeutic windows, significant variability in pharmacokinetics, and a clear correlation between plasma levels and...
582
Drug Therapy01:28

Drug Therapy

423
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
423
Psychosis: Goals of Pharmacotherapy01:26

Psychosis: Goals of Pharmacotherapy

689
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
689
Therapeutic Drug Monitoring: Drug Analysis Methods01:26

Therapeutic Drug Monitoring: Drug Analysis Methods

327
Therapeutic Drug Monitoring (TDM) is a clinical practice that measures specific drug levels in a patient's blood or body tissues to tailor drug therapy effectively. This monitoring is critical for managing drugs with narrow therapeutic indices like digoxin and phenytoin, ensuring they are both safe and effective. For instance, monitoring theophylline levels in asthma patients involves precision and sensitivity to adjust doses according to individual responses to therapy, ensuring efficacy and...
327
Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

802
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
802

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aripiprazole once-monthly for patients diagnosed with bipolar I disorder: Number needed to treat, number needed to harm, and likelihood to be helped or harmed.

Journal of affective disorders·2026
Same author

Understanding the relationship between aripiprazole levels in the blood and recurrence of mood episodes in people diagnosed with bipolar I disorder treated with a once-monthly injection of aripiprazole monohydrate: a plain language summary.

Expert review of clinical pharmacology·2026
Same author

Aripiprazole Once-Monthly for Patients Diagnosed With Schizophrenia: Number Needed to Treat, Number Needed to Harm, and Likelihood to be Helped or Harmed.

The Journal of clinical psychiatry·2026
Same author

Safety and Efficacy of Maintenance Treatment With Aripiprazole Once-Monthly in Black/African American Adults Diagnosed With Bipolar I Disorder: Post Hoc Analysis of a 52-Week, Open-Label Study.

The Journal of clinical psychiatry·2026
Same author

The effect of early initiation of aripiprazole once-monthly 400 mg on health care resource utilization and health care costs in patients diagnosed with bipolar I disorder: Real-world evidence from US claims data.

Journal of managed care & specialty pharmacy·2025
Same author

Exposure-Response Analysis for Aripiprazole Once-Monthly in Patients Diagnosed With Bipolar I Disorder.

Clinical pharmacology in drug development·2025
Same journal

Aripiprazole and Unexpected Salivation: A Case of Drug-Induced Sialorrhea Refractory to Anticholinergics.

Journal of pharmacy practice·2026
Same journal

Exploring Strategies to Educate Reproductive-Aged Individuals About Pharmacist-Prescribed Hormonal Contraception in Indiana: A Qualitative Study.

Journal of pharmacy practice·2026
Same journal

Assessing Kansas Pharmacy Preceptors' Experiences, Knowledge, and Attitudes Toward Pharmacogenomics.

Journal of pharmacy practice·2026
Same journal

The Impact of Academic Detailing on Clinician and Patient Outcomes: A Narrative Review.

Journal of pharmacy practice·2026
Same journal

Management of a Kratom and Tianeptine Overdose.

Journal of pharmacy practice·2026
Same journal

Strategies for Substituting ADHD Medications During Stimulant Shortages.

Journal of pharmacy practice·2026
See all related articles

Related Experiment Video

Updated: Apr 18, 2026

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

1.0K

Psychiatric services: a platform for MTM.

Karimah S Bell Lynum1, Angela M Hill2

  • 1CNS Medical Affairs, Janssen Scientific Affairs, LLC, Titusville, NJ, USA karimah.bell@gmail.com.

Journal of Pharmacy Practice
|January 10, 2015
PubMed
Summary
This summary is machine-generated.

Deinstitutionalization led to increased mental illness in community settings without adequate funding. Pharmacists can now play a key role in managing mental health patients through Medication Therapy Management services.

Keywords:
Medication Therapy Managementcommunitymental illnesspatient educationpsychotropics

More Related Videos

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
12:19

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

17
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

966

Related Experiment Videos

Last Updated: Apr 18, 2026

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

1.0K
Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression
12:19

Robotically Delivered fMRI-Guided Personalized Transcranial Magnetic Stimulation Therapy for Treatment-Resistant Depression

Published on: April 10, 2026

17
Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder
11:17

Protocol for Repetitive Transcranial Magnetic Stimulation with Symptom Provocation to Treat Obsessive-compulsive Disorder

Published on: November 25, 2025

966

Area of Science:

  • Health Services Research
  • Psychiatric Pharmacy
  • Public Health Policy

Background:

  • The deinstitutionalization movement shifted mental illness care from state institutions to communities.
  • Inadequate funding has led to increased mental illness in jails, homeless shelters, and emergency departments.
  • Federal initiatives now aim to improve community mental health services.

Purpose of the Study:

  • To highlight the critical role of pharmacists in managing patients with mental illnesses.
  • To identify opportunities for pharmacists within ambulatory care settings under current health reform.
  • To underscore the necessity of pharmacist involvement in Medication Therapy Management for psychiatric patients.

Main Methods:

  • Review of historical trends in mental health care policy and funding.
  • Analysis of the current healthcare landscape and opportunities for pharmacist integration.
  • Identification of challenges in mental health patient care, including adherence, comorbidities, and polypharmacy.

Main Results:

  • Pharmacists are uniquely positioned to impact treatment outcomes for individuals with mental health conditions.
  • Health reform creates pathways for pharmacists to be integral members of ambulatory care teams.
  • Key challenges such as medication adherence, complex comorbidities, and polypharmacy necessitate expert management.

Conclusions:

  • Pharmacists are essential in providing Medication Therapy Management for patients with mental illnesses.
  • Integrating pharmacists into ambulatory care settings can improve care for this vulnerable population.
  • Addressing medication adherence, comorbidities, and adverse effects is crucial for successful mental health treatment.